Hainan Hailing Cemipharma Corp.
Stage
Unattributed VC | AliveTotal Raised
$17MLast Raised
$17M | 15 yrs agoExpert Collections containing Hainan Hailing Cemipharma Corp.
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Hainan Hailing Cemipharma Corp. is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Where is Hainan Hailing Cemipharma Corp.'s headquarters?
Hainan Hailing Cemipharma Corp.'s headquarters is located at 6 Jinyu Road, Haikou.
What is Hainan Hailing Cemipharma Corp.'s latest funding round?
Hainan Hailing Cemipharma Corp.'s latest funding round is Unattributed VC.
How much did Hainan Hailing Cemipharma Corp. raise?
Hainan Hailing Cemipharma Corp. raised a total of $17M.
Who are the investors of Hainan Hailing Cemipharma Corp.?
Investors of Hainan Hailing Cemipharma Corp. include AIF Captial and Mitsui & Co. Global Investment.
Who are Hainan Hailing Cemipharma Corp.'s competitors?
Competitors of Hainan Hailing Cemipharma Corp. include Neos Therapeutics, OcuNexus Therapeutics, GC-Rise Pharmaceutical, Peckforton Pharmaceuticals, Oceana Therapeutics and 13 more.
You May Also Like
TERAPIA is a company engaged in the development and sale of pharmaceutical products
Xigen develops therapeutic peptides for a range of diseases.
China Nuokang Bio-Pharmaceutical is a China-based biopharmaceutical firm.
ISW Group is a pharmaceutical company that researches and aims to develop FDA approved topical products for the management and treatment of acute and chronic inflammatory skin conditions. ISW Group's research program focuses on acute and chronic dermatologic irritation and inflammation associated with dermatitis, Pseudofolliculitis barbae, burn care and wound healing.
QOL Medical is a specialty pharmaceutical company focused on the gastrointestinal market.
Nycomed is a privately owned global pharmaceutical company with a differentiated portfolio focused on branded medicines in gastroenterology, respiratory diseases, inflammation diseases, pain, osteoporosis and tissue management. nnIts R&D is built to be open for partnerships also beyond its core areas in inflammatory, respiratory diseases and pain as in-licensing is a cornerstone in the company's growth strategy.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.